Drugmaker Merck announces approval of new cholesterol-fighting drug

AI Summary

Merck has received FDA approval for Lipfendra, a new daily pill offering an alternative to statins for lowering LDL cholesterol. This drug provides patients with muscle ache side effects a new treatment option.

Lipfendra can be taken in conjunction with or an alternative to statins, the most prescribed medication in the US Sign up for the Breaking News US newsletter email The drug giant Merck on Thursday announced it had received FDA approval for a daily pill that can be an alternative to statins for treating high LDL levels, or so-called bad cholesterol. The new pill, Lipfendra, is a version of a drug called a PCSK9 inhibitor. For decades the go-to therapy to treat high cholesterol levels has been statins, the most prescribed medication in the US. But statins come occasionally with side effects like muscle aches and they sometimes don’t drop cholesterol levels enough to meet recommended levels. Continue reading...